|
1
|
Tang X, Hu G, Xu C, Ouyang K, Fang W,
Huang W, Zhang J, Li F, Wang K, Qin X, et al: HZ08 reverse the
aneuploidy-induced cisplatin-resistance in gastric cancer by
modulating the p53 pathway. Eur J Pharmacol. 720:84–97. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saika K and Sobue T: Cancer statistics in
the world. Gan To Kagaku Ryoho. 40:2475–2480. 2013.In Japanese.
PubMed/NCBI
|
|
3
|
Nomoto-Kojima N, Aoki S, Uchihashi K,
Matsunobu A, Koike E, Ootani A, Yonemitsu N, Fujimoto K and Toda S:
Interaction between adipose tissue stromal cells and gastric cancer
cells in vitro. Cell Tissue Res. 344:287–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fock KM: Review article: The epidemiology
and prevention of gastric cancer. Aliment Pharmacol Ther.
40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hacker U and Lordick F: Current standards
in the treatment of gastric cancer. Deutsche medizinische
Wochenschrift. 140:1202–1205. 2015.In German.
|
|
6
|
Safarzadeh E, Sandoghchian Shotorbani S
and Baradaran B: Herbal medicine as inducers of apoptosis in cancer
treatment. Adv Pharm Bull. 4(Suppl 1): 421–427. 2014.PubMed/NCBI
|
|
7
|
Li HY, Zhang J, Sun LL, Li BH, Gao HL, Xie
T, Zhang N and Ye ZM: Celastrol induces apoptosis and autophagy via
the ROS/JNK signaling pathway in human osteosarcoma cells: An in
vitro and in vivo study. Cell Death Dis. 6:e16042015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang HH, Kuang S, Wang Y, Sun XX, Gu Y,
Hu LH and Yu Q: Bigelovin inhibits STAT3 signaling by inactivating
JAK2 and induces apoptosis in human cancer cells. Acta Pharmacol
Sin. 36:507–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xin Y, Yin F, Qi S, Shen L, Xu Y, Luo L,
Lan L and Yin Z: Parthenolide reverses doxorubicin resistance in
human lung carcinoma A549 cells by attenuating NF-κB activation and
HSP70 up-regulation. Toxicol Lett. 221:73–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin LL, Hsia CR, Hsu CL, Huang HC and Juan
HF: Integrating transcriptomics and proteomics to show that
tanshinone IIA suppresses cell growth by blocking glucose
metabolism in gastric cancer cells. BMC Genomics. 16:412015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye B, Li J, Li Z, Yang J, Niu T and Wang
S: Anti-tumor activity and relative mechanism of ethanolic extract
of Marsdenia tenacissima (Asclepiadaceae) against human hematologic
neoplasm in vitro and in vivo. J Ethnopharmacol. 153:258–267. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kocevski D, Du M, Kan J, Jing C, Lačanin I
and Pavlović H: Antifungal effect of Allium tuberosum, Cinnamomum
cassia, and Pogostemon cablin essential oils and their components
against population of Aspergillus species. J Food Sci.
78:M731–M737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim DW, Chi YS, Son KH, Chang HW, Kim JS,
Kang SS and Kim HP: Effects of sophoraflavanone G, a prenylated
flavonoid from Sophora flavescens, on cyclooxygenase-2 and in vivo
inflammatory response. Arch Pharm Res. 25:329–335. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang JS, Lee SA, Hong SS, Lee KS, Lee MK,
Hwang BY and Ro JS: Monoamine oxidase inhibitory components from
the roots of Sophora flavescens. Arch Pharm Res. 28:190–194. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung HJ, Kang SS, Hyun SK and Choi JS: In
vitro free radical and ONOO- scavengers from Sophora flavescens.
Arch Pharm Res. 28:534–540. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujise Y, Toda T and Itô S: Isolation of
trifolirhizin from Ononis spinosa L. Chem Pharm Bull (Tokyo).
13:93–95. 1965. View Article : Google Scholar
|
|
17
|
Zhang C, Ma Y, Gao HM, Liu XQ, Chen LM,
Zhang QW, Wang ZM and Li AP: Non-alkaloid components from Sophora
flavescens. Zhongguo Zhong Yao Za Zhi. 38:3520–3524. 2013.In
Chinese.
|
|
18
|
Abdel-Kader MS: Preliminary
pharmacological study of the pterocarpans macckian and
trifolirhizin isolated from the roots of Ononis vaginalis. Pak J
Pharm Sci. 23:182–187. 2010.PubMed/NCBI
|
|
19
|
Zhou H, Lutterodt H, Cheng Z and Yu LL:
Anti-inflammatory and antiproliferative activities of
trifolirhizin, a flavonoid from Sophora flavescens roots. J Agric
Food Chem. 57:4580–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang N, Liang B, Srivastava K, Zeng J,
Zhan J, Brown L, Sampson H, Goldfarb J, Emala C and Li XM: The
Sophora flavescens flavonoid compound trifolirhizin inhibits
acetylcholine induced airway smooth muscle contraction.
Phytochemistry. 95:259–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hyun SK, Lee WH, Jeong DM, Kim Y and Choi
JS: Inhibitory effects of kurarinol, kuraridinol, and trifolirhizin
from Sophora flavescens on tyrosinase and melanin synthesis. Biol
Pharm Bull. 31:154–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin T, Yang G, Ma Y, Xu B, Hu M, You M and
Gao S: Developing an activity and absorption-based quality control
platform for Chinese traditional medicine: Application to
Zeng-Sheng-Ping (Antitumor B). J Ethnopharmacol. 172:195–201. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aratanechemuge Y, Hibasami H, Katsuzaki H,
Imai K and Komiya T: Induction of apoptosis by maackiain and
trifolirhizin (maackiain glycoside) isolated from sanzukon (Sophora
Subprostrate Chen et T. Chen) in human promyelotic leukemia HL-60
cells. Oncol Rep. 12:1183–1188. 2004.PubMed/NCBI
|
|
24
|
Lindén SK, Driessen KM and McGuckin MA:
Improved in vitro model systems for gastrointestinal infection by
choice of cell line, pH, microaerobic conditions, and optimization
of culture conditions. Helicobacter. 12:341–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Giard DJ, Aaronson SA, Todaro GJ, Arnstein
P, Kersey JH, Dosik H and Parks WP: In vitro cultivation of human
tumors: Establishment of cell lines derived from a series of solid
tumors. J Natl Cancer Inst. 51:1417–1423. 1973.PubMed/NCBI
|
|
26
|
Thomas S, Quinn BA, Das SK, Dash R, Emdad
L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, et al:
Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther
Targets. 17:61–75. 2013. View Article : Google Scholar
|
|
27
|
Yu H, Zhang T, Cai L, Qu Y, Hu S, Dong G,
Guan R, Xu X and Xing L: Chamaejasmine induces apoptosis in human
lung adenocarcinoma A549 cells through a Ros-mediated mitochondrial
pathway. Molecules. 16:8165–8180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Llambi F and Green DR: Apoptosis and
oncogenesis: Give and take in the BCL-2 family. Curr Opin Genet
Dev. 21:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bah N, Maillet L, Ryan J, Dubreil S,
Gautier F, Letai A, Juin P and Barillé-Nion S: Bcl-xL controls a
switch between cell death modes during mitotic arrest. Cell Death
Dis. 5:e12912014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
David R: Apoptosis: A lipid trigger of
MOMP. Nat Rev Mol Cell Biol. 13:208–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carduner L, Picot CR, Leroy-Dudal J, Blay
L, Kellouche S and Carreiras F: Cell cycle arrest or survival
signaling through αv integrins, activation of PKC and ERK1/2 lead
to anoikis resistance of ovarian cancer spheroids. Exp Cell Res.
320:329–342. 2014. View Article : Google Scholar
|
|
34
|
Romanov V, Whyard TC, Waltzer WC, Grollman
AP and Rosenquist T: Aristolochic acid-induced apoptosis and G2
cell cycle arrest depends on ROS generation and MAP kinases
activation. Arch Toxicol. 89:47–56. 2015. View Article : Google Scholar
|
|
35
|
Li L, Gao Y, Zhang L, Zeng J, He D and Sun
Y: Silibinin inhibits cell growth and induces apoptosis by caspase
activation, down-regulating survivin and blocking EGFR-ERK
activation in renal cell carcinoma. Cancer Lett. 272:61–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
